Structure

Physi-Chem Properties

Molecular Weight:  376.19
Volume:  391.582
LogP:  2.248
LogD:  2.749
LogS:  -3.592
# Rotatable Bonds:  11
TPSA:  77.38
# H-Bond Aceptor:  6
# H-Bond Donor:  2
# Rings:  2
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.628
Synthetic Accessibility Score:  2.629
Fsp3:  0.429
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.486
MDCK Permeability:  5.249829700915143e-05
Pgp-inhibitor:  0.976
Pgp-substrate:  0.043
Human Intestinal Absorption (HIA):  0.002
20% Bioavailability (F20%):  0.005
30% Bioavailability (F30%):  0.01

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.367
Plasma Protein Binding (PPB):  73.54145050048828%
Volume Distribution (VD):  0.58
Pgp-substrate:  7.584928035736084%

ADMET: Metabolism

CYP1A2-inhibitor:  0.359
CYP1A2-substrate:  0.82
CYP2C19-inhibitor:  0.458
CYP2C19-substrate:  0.79
CYP2C9-inhibitor:  0.16
CYP2C9-substrate:  0.744
CYP2D6-inhibitor:  0.721
CYP2D6-substrate:  0.931
CYP3A4-inhibitor:  0.93
CYP3A4-substrate:  0.663

ADMET: Excretion

Clearance (CL):  9.212
Half-life (T1/2):  0.869

ADMET: Toxicity

hERG Blockers:  0.273
Human Hepatotoxicity (H-HT):  0.189
Drug-inuced Liver Injury (DILI):  0.391
AMES Toxicity:  0.02
Rat Oral Acute Toxicity:  0.004
Maximum Recommended Daily Dose:  0.349
Skin Sensitization:  0.713
Carcinogencity:  0.479
Eye Corrosion:  0.003
Eye Irritation:  0.046
Respiratory Toxicity:  0.017

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC71079

Natural Product ID:  NPC71079
Common Name*:   Amphimedoside E
IUPAC Name:   (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[methoxy-[(Z)-14-pyridin-3-yltetradec-5-enyl]amino]oxane-3,4,5-triol
Synonyms:   Amphimedoside E
Standard InCHIKey:  YPJONPXFFNCTJJ-OGUBVRRVSA-N
Standard InCHI:  InChI=1S/C26H44N2O6/c1-33-28(26-25(32)24(31)23(30)22(20-29)34-26)18-13-11-9-7-5-3-2-4-6-8-10-12-15-21-16-14-17-27-19-21/h5,7,14,16-17,19,22-26,29-32H,2-4,6,8-13,15,18,20H2,1H3/b7-5-/t22-,23-,24+,25-,26-/m1/s1
SMILES:  CON([C@@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O)CCCC/C=CCCCCCCCCc1cccnc1
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL465624
PubChem CID:   16091665
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0004603] Organic oxygen compounds
      • [CHEMONTID:0000323] Organooxygen compounds
        • [CHEMONTID:0000011] Carbohydrates and carbohydrate conjugates
          • [CHEMONTID:0002105] Glycosyl compounds
            • [CHEMONTID:0002203] Glycosylamines

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33243 Amphimedon sp. Species Niphatidae Eukaryota n.a. Iojima Island, the Satsunan Islands, southern Japan (3047 N; 13017 E) n.a. PMID[15497958]
NPO33243 Amphimedon sp. Species Niphatidae Eukaryota n.a. n.a. n.a. PMID[17067172]
NPO33243 Amphimedon sp. Species Niphatidae Eukaryota n.a. Republic of Palau 2006; 2007 PMID[20681583]
NPO33243 Amphimedon sp. Species Niphatidae Eukaryota n.a. n.a. n.a. PMID[28207259]
NPO33243 Amphimedon sp. Species Niphatidae Eukaryota n.a. n.a. n.a. PMID[7714542]
NPO33243 Amphimedon sp. Species Niphatidae Eukaryota n.a. n.a. n.a. PMID[9599281]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT168 Cell Line P388 Mus musculus IC50 = 2.2 ug.mL-1 PMID[475113]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC71079 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9933 High Similarity NPC474217
0.9801 High Similarity NPC278366
0.9801 High Similarity NPC127730
0.9735 High Similarity NPC85918
0.8246 Intermediate Similarity NPC62510
0.8199 Intermediate Similarity NPC138018
0.7867 Intermediate Similarity NPC471311
0.7867 Intermediate Similarity NPC471313
0.7857 Intermediate Similarity NPC319456
0.7838 Intermediate Similarity NPC290094
0.7747 Intermediate Similarity NPC149708
0.7697 Intermediate Similarity NPC89490
0.7688 Intermediate Similarity NPC471323
0.7682 Intermediate Similarity NPC202957
0.7682 Intermediate Similarity NPC169625
0.7647 Intermediate Similarity NPC329896
0.7647 Intermediate Similarity NPC475090
0.7647 Intermediate Similarity NPC475105
0.764 Intermediate Similarity NPC328798
0.7614 Intermediate Similarity NPC325093
0.7574 Intermediate Similarity NPC476446
0.7574 Intermediate Similarity NPC78375
0.7574 Intermediate Similarity NPC469813
0.7542 Intermediate Similarity NPC325775
0.7528 Intermediate Similarity NPC318020
0.7514 Intermediate Similarity NPC327373
0.7514 Intermediate Similarity NPC322043
0.75 Intermediate Similarity NPC182814
0.7486 Intermediate Similarity NPC20593
0.7436 Intermediate Similarity NPC324611
0.7427 Intermediate Similarity NPC477975
0.7421 Intermediate Similarity NPC471312
0.7418 Intermediate Similarity NPC127647
0.7401 Intermediate Similarity NPC317010
0.7326 Intermediate Similarity NPC160127
0.7326 Intermediate Similarity NPC50997
0.7325 Intermediate Similarity NPC256893
0.729 Intermediate Similarity NPC212125
0.729 Intermediate Similarity NPC165370
0.7267 Intermediate Similarity NPC40779
0.7261 Intermediate Similarity NPC315320
0.7254 Intermediate Similarity NPC472752
0.7247 Intermediate Similarity NPC133261
0.7234 Intermediate Similarity NPC474767
0.7232 Intermediate Similarity NPC203754
0.7232 Intermediate Similarity NPC472122
0.7232 Intermediate Similarity NPC24594
0.7232 Intermediate Similarity NPC150048
0.7225 Intermediate Similarity NPC471178
0.7208 Intermediate Similarity NPC476322
0.72 Intermediate Similarity NPC471402
0.72 Intermediate Similarity NPC297486
0.72 Intermediate Similarity NPC240136
0.7188 Intermediate Similarity NPC309498
0.7184 Intermediate Similarity NPC108469
0.7168 Intermediate Similarity NPC311276
0.7151 Intermediate Similarity NPC141377
0.7143 Intermediate Similarity NPC29702
0.7143 Intermediate Similarity NPC292517
0.7135 Intermediate Similarity NPC473763
0.7135 Intermediate Similarity NPC129721
0.7135 Intermediate Similarity NPC117244
0.7111 Intermediate Similarity NPC472105
0.7111 Intermediate Similarity NPC187827
0.7107 Intermediate Similarity NPC471322
0.7105 Intermediate Similarity NPC79223
0.7095 Intermediate Similarity NPC326575
0.709 Intermediate Similarity NPC470499
0.709 Intermediate Similarity NPC59033
0.7078 Intermediate Similarity NPC329825
0.7074 Intermediate Similarity NPC292361
0.7072 Intermediate Similarity NPC470474
0.707 Intermediate Similarity NPC306397
0.7069 Intermediate Similarity NPC473057
0.7068 Intermediate Similarity NPC328559
0.7068 Intermediate Similarity NPC32451
0.7062 Intermediate Similarity NPC470498
0.7059 Intermediate Similarity NPC289786
0.7056 Intermediate Similarity NPC476467
0.7047 Intermediate Similarity NPC25442
0.7047 Intermediate Similarity NPC12944
0.7044 Intermediate Similarity NPC69914
0.7039 Intermediate Similarity NPC91958
0.7037 Intermediate Similarity NPC329024
0.7035 Intermediate Similarity NPC469762
0.7035 Intermediate Similarity NPC30570
0.7033 Intermediate Similarity NPC472110
0.7033 Intermediate Similarity NPC472109
0.7031 Intermediate Similarity NPC476874
0.7026 Intermediate Similarity NPC63041
0.7022 Intermediate Similarity NPC314603
0.7016 Intermediate Similarity NPC470497
0.7011 Intermediate Similarity NPC124542
0.7011 Intermediate Similarity NPC59779
0.7011 Intermediate Similarity NPC471177
0.7 Intermediate Similarity NPC162812
0.7 Intermediate Similarity NPC317672
0.7 Intermediate Similarity NPC324245
0.7 Intermediate Similarity NPC320748
0.7 Intermediate Similarity NPC153769
0.699 Remote Similarity NPC48042
0.699 Remote Similarity NPC304179
0.699 Remote Similarity NPC472550
0.6989 Remote Similarity NPC160105
0.6989 Remote Similarity NPC98187
0.6989 Remote Similarity NPC54988
0.6985 Remote Similarity NPC313640
0.6981 Remote Similarity NPC476131
0.6977 Remote Similarity NPC469785
0.6974 Remote Similarity NPC156044
0.697 Remote Similarity NPC472553
0.6966 Remote Similarity NPC89562
0.6959 Remote Similarity NPC27802
0.6957 Remote Similarity NPC188387
0.6957 Remote Similarity NPC322488
0.6957 Remote Similarity NPC163421
0.695 Remote Similarity NPC477910
0.6943 Remote Similarity NPC146373
0.6943 Remote Similarity NPC245244
0.6943 Remote Similarity NPC166424
0.694 Remote Similarity NPC139291
0.694 Remote Similarity NPC472108
0.694 Remote Similarity NPC469358
0.6936 Remote Similarity NPC132680
0.6936 Remote Similarity NPC269919
0.6931 Remote Similarity NPC472555
0.6923 Remote Similarity NPC477974
0.6919 Remote Similarity NPC63562
0.6915 Remote Similarity NPC471014
0.6915 Remote Similarity NPC475408
0.6915 Remote Similarity NPC206343
0.6915 Remote Similarity NPC477908
0.6903 Remote Similarity NPC48564
0.6903 Remote Similarity NPC182570
0.6903 Remote Similarity NPC265605
0.6902 Remote Similarity NPC207851
0.6893 Remote Similarity NPC474561
0.6893 Remote Similarity NPC49954
0.6884 Remote Similarity NPC111732
0.6881 Remote Similarity NPC314270
0.6881 Remote Similarity NPC294579
0.6881 Remote Similarity NPC144779
0.6875 Remote Similarity NPC263439
0.6875 Remote Similarity NPC97367
0.6866 Remote Similarity NPC470306
0.6864 Remote Similarity NPC161292
0.686 Remote Similarity NPC73952
0.686 Remote Similarity NPC469763
0.686 Remote Similarity NPC25008
0.686 Remote Similarity NPC469765
0.686 Remote Similarity NPC476492
0.686 Remote Similarity NPC469760
0.686 Remote Similarity NPC259644
0.686 Remote Similarity NPC469786
0.6857 Remote Similarity NPC63338
0.6857 Remote Similarity NPC324203
0.6857 Remote Similarity NPC322976
0.6855 Remote Similarity NPC278451
0.6848 Remote Similarity NPC163055
0.6833 Remote Similarity NPC477976
0.6832 Remote Similarity NPC471016
0.6832 Remote Similarity NPC6981
0.6831 Remote Similarity NPC471997
0.6829 Remote Similarity NPC477911
0.6821 Remote Similarity NPC211572
0.6821 Remote Similarity NPC80597
0.6821 Remote Similarity NPC70922
0.6821 Remote Similarity NPC212376
0.6821 Remote Similarity NPC75540
0.6818 Remote Similarity NPC282231
0.6818 Remote Similarity NPC143603
0.6816 Remote Similarity NPC228331
0.6816 Remote Similarity NPC319128
0.6811 Remote Similarity NPC284559
0.6809 Remote Similarity NPC95783
0.6802 Remote Similarity NPC475835
0.68 Remote Similarity NPC230869
0.6798 Remote Similarity NPC62367
0.6796 Remote Similarity NPC469938
0.6793 Remote Similarity NPC233936
0.6789 Remote Similarity NPC279401
0.6789 Remote Similarity NPC79293
0.6786 Remote Similarity NPC118832
0.6786 Remote Similarity NPC165349
0.6786 Remote Similarity NPC329708
0.6786 Remote Similarity NPC274291
0.6786 Remote Similarity NPC264166
0.6786 Remote Similarity NPC47059
0.6782 Remote Similarity NPC477909
0.6782 Remote Similarity NPC42678
0.6782 Remote Similarity NPC477907
0.678 Remote Similarity NPC194640
0.6779 Remote Similarity NPC244536
0.6778 Remote Similarity NPC158129
0.6769 Remote Similarity NPC193761
0.6766 Remote Similarity NPC165837
0.6765 Remote Similarity NPC301368
0.6765 Remote Similarity NPC84815
0.6765 Remote Similarity NPC216428
0.6763 Remote Similarity NPC475498

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC71079 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7935 Intermediate Similarity NPD1380 Discovery
0.7853 Intermediate Similarity NPD2544 Clinical (unspecified phase)
0.7848 Intermediate Similarity NPD1427 Clinical (unspecified phase)
0.7831 Intermediate Similarity NPD4239 Clinical (unspecified phase)
0.7785 Intermediate Similarity NPD1383 Phase 3
0.7785 Intermediate Similarity NPD1382 Phase 2
0.7644 Intermediate Similarity NPD8037 Clinical (unspecified phase)
0.7644 Intermediate Similarity NPD8036 Clinical (unspecified phase)
0.7557 Intermediate Similarity NPD8408 Discontinued
0.7542 Intermediate Similarity NPD8021 Approved
0.7542 Intermediate Similarity NPD8020 Approved
0.7532 Intermediate Similarity NPD9506 Approved
0.7486 Intermediate Similarity NPD8123 Approved
0.7486 Intermediate Similarity NPD8122 Approved
0.7484 Intermediate Similarity NPD2896 Discontinued
0.7469 Intermediate Similarity NPD3813 Approved
0.7459 Intermediate Similarity NPD8063 Discontinued
0.7442 Intermediate Similarity NPD5862 Discovery
0.7439 Intermediate Similarity NPD4702 Approved
0.7439 Intermediate Similarity NPD4703 Approved
0.7425 Intermediate Similarity NPD5358 Clinical (unspecified phase)
0.7425 Intermediate Similarity NPD2809 Approved
0.7407 Intermediate Similarity NPD3717 Discontinued
0.7396 Intermediate Similarity NPD5255 Approved
0.7381 Intermediate Similarity NPD6026 Approved
0.7362 Intermediate Similarity NPD1352 Discontinued
0.7353 Intermediate Similarity NPD2511 Approved
0.7346 Intermediate Similarity NPD4805 Approved
0.7337 Intermediate Similarity NPD2582 Approved
0.7337 Intermediate Similarity NPD2581 Approved
0.731 Intermediate Similarity NPD8026 Phase 1
0.7297 Intermediate Similarity NPD4427 Phase 2
0.729 Intermediate Similarity NPD9284 Approved
0.7288 Intermediate Similarity NPD5751 Clinical (unspecified phase)
0.7284 Intermediate Similarity NPD1649 Discontinued
0.7262 Intermediate Similarity NPD2012 Clinical (unspecified phase)
0.7261 Intermediate Similarity NPD9207 Approved
0.7261 Intermediate Similarity NPD9206 Approved
0.7244 Intermediate Similarity NPD1095 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD4804 Approved
0.7184 Intermediate Similarity NPD4174 Clinical (unspecified phase)
0.7169 Intermediate Similarity NPD6148 Clinical (unspecified phase)
0.7168 Intermediate Similarity NPD6635 Approved
0.7168 Intermediate Similarity NPD5088 Discontinued
0.7152 Intermediate Similarity NPD751 Clinical (unspecified phase)
0.7151 Intermediate Similarity NPD8304 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD7913 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD4670 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD4669 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD4671 Clinical (unspecified phase)
0.7102 Intermediate Similarity NPD4184 Clinical (unspecified phase)
0.707 Intermediate Similarity NPD2119 Approved
0.707 Intermediate Similarity NPD9080 Approved
0.707 Intermediate Similarity NPD2118 Approved
0.7066 Intermediate Similarity NPD7469 Discontinued
0.7063 Intermediate Similarity NPD1627 Clinical (unspecified phase)
0.7055 Intermediate Similarity NPD203 Clinical (unspecified phase)
0.7049 Intermediate Similarity NPD3082 Discontinued
0.7045 Intermediate Similarity NPD6872 Clinical (unspecified phase)
0.7031 Intermediate Similarity NPD5721 Clinical (unspecified phase)
0.7025 Intermediate Similarity NPD5352 Clinical (unspecified phase)
0.7022 Intermediate Similarity NPD2076 Approved
0.7022 Intermediate Similarity NPD2077 Approved
0.7 Intermediate Similarity NPD3262 Approved
0.7 Intermediate Similarity NPD8325 Phase 3
0.7 Intermediate Similarity NPD8327 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD8326 Phase 3
0.697 Remote Similarity NPD1395 Clinical (unspecified phase)
0.6968 Remote Similarity NPD4529 Approved
0.6968 Remote Similarity NPD4528 Approved
0.6968 Remote Similarity NPD4526 Approved
0.6957 Remote Similarity NPD6227 Discontinued
0.6952 Remote Similarity NPD4699 Discontinued
0.6943 Remote Similarity NPD5486 Discontinued
0.6937 Remote Similarity NPD3475 Approved
0.6937 Remote Similarity NPD3476 Approved
0.6936 Remote Similarity NPD9383 Approved
0.6936 Remote Similarity NPD9382 Approved
0.6935 Remote Similarity NPD4021 Phase 2
0.6923 Remote Similarity NPD1661 Suspended
0.6914 Remote Similarity NPD3944 Approved
0.6914 Remote Similarity NPD3942 Approved
0.6906 Remote Similarity NPD1032 Phase 2
0.6903 Remote Similarity NPD270 Clinical (unspecified phase)
0.6903 Remote Similarity NPD268 Approved
0.6903 Remote Similarity NPD271 Approved
0.6889 Remote Similarity NPD5322 Clinical (unspecified phase)
0.6882 Remote Similarity NPD3575 Approved
0.6882 Remote Similarity NPD3576 Approved
0.6875 Remote Similarity NPD8129 Discovery
0.6872 Remote Similarity NPD7396 Approved
0.6869 Remote Similarity NPD8321 Discontinued
0.6867 Remote Similarity NPD4824 Approved
0.6867 Remote Similarity NPD4823 Approved
0.6857 Remote Similarity NPD687 Clinical (unspecified phase)
0.6857 Remote Similarity NPD9398 Clinical (unspecified phase)
0.6854 Remote Similarity NPD4640 Approved
0.6854 Remote Similarity NPD4638 Approved
0.6854 Remote Similarity NPD4639 Approved
0.6852 Remote Similarity NPD1993 Approved
0.6852 Remote Similarity NPD1995 Approved
0.6852 Remote Similarity NPD1994 Approved
0.6851 Remote Similarity NPD5100 Phase 3
0.6851 Remote Similarity NPD6375 Clinical (unspecified phase)
0.6845 Remote Similarity NPD7234 Approved
0.6845 Remote Similarity NPD7233 Approved
0.6842 Remote Similarity NPD7944 Discontinued
0.6839 Remote Similarity NPD5541 Clinical (unspecified phase)
0.6837 Remote Similarity NPD5458 Discontinued
0.6829 Remote Similarity NPD792 Discontinued
0.6828 Remote Similarity NPD4375 Approved
0.6825 Remote Similarity NPD6569 Phase 2
0.6818 Remote Similarity NPD6529 Discontinued
0.681 Remote Similarity NPD4029 Approved
0.681 Remote Similarity NPD4030 Approved
0.681 Remote Similarity NPD4028 Approved
0.6809 Remote Similarity NPD3321 Discontinued
0.6792 Remote Similarity NPD9583 Approved
0.679 Remote Similarity NPD9726 Discontinued
0.6786 Remote Similarity NPD4035 Approved
0.6786 Remote Similarity NPD31 Approved
0.6786 Remote Similarity NPD7712 Clinical (unspecified phase)
0.6786 Remote Similarity NPD4122 Approved
0.6786 Remote Similarity NPD4039 Approved
0.6786 Remote Similarity NPD4036 Approved
0.6786 Remote Similarity NPD4037 Approved
0.6786 Remote Similarity NPD4038 Approved
0.6786 Remote Similarity NPD4034 Approved
0.6786 Remote Similarity NPD3525 Discontinued
0.6786 Remote Similarity NPD4033 Approved
0.6786 Remote Similarity NPD32 Approved
0.678 Remote Similarity NPD6298 Discontinued
0.6779 Remote Similarity NPD4086 Phase 1
0.6778 Remote Similarity NPD5934 Clinical (unspecified phase)
0.6776 Remote Similarity NPD1620 Clinical (unspecified phase)
0.6774 Remote Similarity NPD6241 Phase 1
0.6772 Remote Similarity NPD6626 Approved
0.6765 Remote Similarity NPD4555 Clinical (unspecified phase)
0.676 Remote Similarity NPD5069 Clinical (unspecified phase)
0.676 Remote Similarity NPD7287 Clinical (unspecified phase)
0.6755 Remote Similarity NPD6068 Discontinued
0.6751 Remote Similarity NPD6732 Clinical (unspecified phase)
0.675 Remote Similarity NPD992 Clinical (unspecified phase)
0.675 Remote Similarity NPD991 Phase 2
0.6743 Remote Similarity NPD820 Phase 3
0.6739 Remote Similarity NPD6595 Phase 3
0.6732 Remote Similarity NPD269 Clinical (unspecified phase)
0.6728 Remote Similarity NPD715 Phase 3
0.6725 Remote Similarity NPD2089 Clinical (unspecified phase)
0.6721 Remote Similarity NPD4072 Approved
0.6721 Remote Similarity NPD4071 Approved
0.6717 Remote Similarity NPD8410 Clinical (unspecified phase)
0.6704 Remote Similarity NPD5611 Phase 2
0.6703 Remote Similarity NPD7414 Clinical (unspecified phase)
0.6703 Remote Similarity NPD3386 Phase 2
0.6702 Remote Similarity NPD1034 Phase 3
0.6702 Remote Similarity NPD1033 Clinical (unspecified phase)
0.6702 Remote Similarity NPD4551 Phase 2
0.6699 Remote Similarity NPD6553 Clinical (unspecified phase)
0.6685 Remote Similarity NPD2123 Phase 3
0.6684 Remote Similarity NPD5555 Phase 1
0.6684 Remote Similarity NPD1229 Phase 2
0.6682 Remote Similarity NPD8372 Clinical (unspecified phase)
0.6667 Remote Similarity NPD9357 Approved
0.6667 Remote Similarity NPD6363 Clinical (unspecified phase)
0.6667 Remote Similarity NPD5596 Phase 2
0.6667 Remote Similarity NPD8110 Clinical (unspecified phase)
0.6667 Remote Similarity NPD4396 Clinical (unspecified phase)
0.6649 Remote Similarity NPD3039 Clinical (unspecified phase)
0.6648 Remote Similarity NPD925 Approved
0.6648 Remote Similarity NPD926 Approved
0.6646 Remote Similarity NPD1598 Discontinued
0.6632 Remote Similarity NPD7061 Clinical (unspecified phase)
0.6631 Remote Similarity NPD1096 Discontinued
0.663 Remote Similarity NPD2620 Phase 2
0.663 Remote Similarity NPD4973 Approved
0.663 Remote Similarity NPD2619 Clinical (unspecified phase)
0.6629 Remote Similarity NPD2061 Approved
0.6628 Remote Similarity NPD1270 Approved
0.662 Remote Similarity NPD7558 Phase 2
0.6616 Remote Similarity NPD8169 Discontinued
0.6615 Remote Similarity NPD6361 Phase 2
0.6615 Remote Similarity NPD6661 Clinical (unspecified phase)
0.6614 Remote Similarity NPD6257 Clinical (unspecified phase)
0.6613 Remote Similarity NPD1783 Clinical (unspecified phase)
0.6612 Remote Similarity NPD2928 Phase 2
0.661 Remote Similarity NPD3433 Clinical (unspecified phase)
0.6609 Remote Similarity NPD510 Phase 1
0.6609 Remote Similarity NPD9706 Clinical (unspecified phase)
0.6609 Remote Similarity NPD5965 Clinical (unspecified phase)
0.6607 Remote Similarity NPD2075 Approved
0.6607 Remote Similarity NPD2071 Approved
0.6607 Remote Similarity NPD2073 Approved
0.6607 Remote Similarity NPD2069 Approved
0.6607 Remote Similarity NPD2068 Approved
0.6607 Remote Similarity NPD2072 Approved
0.6607 Remote Similarity NPD2070 Approved
0.6607 Remote Similarity NPD2074 Approved
0.6599 Remote Similarity NPD6477 Clinical (unspecified phase)
0.6598 Remote Similarity NPD2952 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data